• Products
  • Catalogues
  • News & Trends
  • Exhibitions

Neurology Brochure - 6 Pages

  1. P. 1

  2. P. 2

  3. P. 3

  4. P. 4

  5. P. 5

  6. P. 6

Catalogue excerpts

Blood will tell. The Simoa™ Platform-Detecting CNS biomarkers in serum and plasma with ultra-sensitivity. Quanterix The Science of Precision Health

 Open the catalogue to page 1

Quanterix The Science of Precision Health With a sensitivity more than 1,000 times greater than traditional ELISA methods, the Simoa Platform is so sensitive it can detect biomarkers in blood, offering you another dimension of data from a readily available, non-invasive source. Suddenly new areas of research become practical. Your productivity will increase. Most important, you’ll have access to CNS biomarker data at a level never before possible. Now you can: • Use serum or plasma to detect CNS biomarkers at both acute and normal levels • Understand a neurological disorder’s long-term effects...

 Open the catalogue to page 2

In the past, running immunoassays was a time consuming, largely manual technique. No more. • Throughput: 68 tests/hour, >500 data points per day The HD-1 Analyzer simplifies the process by performing every step of the assay, improving efficiencies while providing consistent, reliable results. It is a fully automated solution that traps single molecules in femtoliter-sized wells, giving you a digital readout of every bead that is bound • Sample Input: 96-well plate or tubes • Total Assay Time: <2.5 hours per 96-well plate • Hands on Time: Startup time <20 minutes • Multiplex Capability: Up to 4-plex Sample...

 Open the catalogue to page 3

Ultra-sensitive Simoa assays for neurology. Alzheimer’s Disease Inflammatory Cytokines Epilepsy Frontotemporal Dementia Major Depressive Disorder Motor Neuron Disease (ALS) Stroke Traumatic Brain Injury The Simoa Accelerator— your easy-to-access link to the Simoa Platform All of the benefits of The Simoa Platform are available to you through the Simoa Accelerator. By using this service, you gain access to a dedicated laboratory and trained professionals ready to help you with custom assay development, reagent development, formulation and sample testing. There is simply no easier, faster way of...

 Open the catalogue to page 4

Quanterix The Science of Precision Health Serum Tau levels predict neurological outcome after hypoxic brain injury from cardiac arrest.* The Simoa Platform is fulfilling an unmet clinical need by objectively measuring the severity of brain injuries and predicting clinical outcomes. In a study, blood samples were collected from 25 cardiac arrest patients that had been resuscitated. Time-dependent elevations of serum Tau were observed in all patients. These measurements were highly predictive of neurological outcome after 6 months, predicting poor and good outcomes with 91% sensitivity and 100%...

 Open the catalogue to page 5

Quanterix' The Science of Precision Health Learn more about how the Simoa Platform can advance your CNS biomarker detection. Visit www.quanterix.com or email info@quanterix.com About Quanterix Quanterix is on a mission to change the way healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced management team, renowned scientists, leading investors and expert advisors to form a collaborative ecosystem, united through the common goal of advancing the science of...

 Open the catalogue to page 6

All Quanterix catalogues and technical brochures

  1. SR X

    2 Pages

    En